Mounjaro Cost UK: NHS vs Private Prescription Prices

Understanding the cost of Mounjaro (tirzepatide) is essential for patients considering this treatment for type 2 diabetes or weight management in the UK. Mounjaro cost varies significantly depending on whether you access it through the NHS or via private prescription. NHS patients meeting eligibility criteria may pay the standard prescription charge of £9.90 in England, whilst private prescriptions typically cost £183.94–£313.94 (price-comparison listing, checked 27 September 2026) monthly. This article explores Mounjaro pricing, factors affecting costs, and pathways to access this dual GIP/GLP-1 receptor agonist, helping you make informed decisions about your treatment options.

What Is Mounjaro and What Is It Used For?

Mounjaro (tirzepatide) is a prescription medicine licensed in the UK for the treatment of type 2 diabetes mellitus in adults.^[2][7] It is also authorised for chronic weight management in adults with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) with at least one weight-related comorbidity.

Mounjaro belongs to a class of medications known as dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonists. By mimicking the action of these naturally occurring hormones, Mounjaro helps to regulate blood sugar levels, enhance insulin secretion when glucose is elevated, reduce glucagon release, slow gastric emptying, and reduce appetite.

Administered as a once-weekly subcutaneous injection, Mounjaro is typically prescribed for diabetes when diet and exercise alone, or other diabetes medications, have not achieved adequate glycaemic control. Clinical trials have demonstrated that tirzepatide can significantly reduce HbA1c levels and support weight loss.

Mounjaro has shown positive effects on metabolic parameters in clinical studies, though long-term cardiovascular outcome data are still emerging. The Medicines and Healthcare products Regulatory Agency (MHRA) approved Mounjaro for use in the UK, and it is available through both NHS and private prescriptions, subject to clinical eligibility criteria.

It is important to note that Mounjaro is not indicated for type 1 diabetes and should not be used as a substitute for insulin. Patients should only use Mounjaro under the supervision of a qualified healthcare professional, following a thorough assessment of their medical history, current medications, and treatment goals. Always discuss potential benefits and risks with your GP or specialist before starting this medication.

How Much Does Mounjaro Cost in the UK?

The cost of Mounjaro in the UK varies significantly depending on whether it is obtained through the NHS or via a private prescription. For eligible patients, Mounjaro may be available on the NHS at the standard prescription charge, which is currently £9.^[13][14]90 per item in England (as of 2024). Patients in Scotland, Wales, and Northern Ireland benefit from free NHS prescriptions. In England, many patients qualify for prescription charge exemptions, and those requiring regular medications may benefit from prescription prepayment certificates.

NHS access to Mounjaro is subject to specific clinical criteria, as outlined in NICE guidance. For diabetes, this typically includes patients who have not achieved target HbA1c levels despite optimised therapy with other agents. For weight management, NICE recommends tirzepatide within specific BMI thresholds and when certain other criteria are met.

For those seeking Mounjaro through private healthcare, the cost is considerably higher. A pack of 4 single-use pens (providing 4 weekly doses) typically ranges from £183.94–£313.94 (price-comparison listing, checked 27 September 2026) (as of 2024), depending on the pharmacy, dosage strength, and any associated consultation fees. Over the course of a month, this equates to approximately £183.94–£313.94, and annual costs can exceed £2,210–£3,770. These figures do not include initial consultations, follow-up appointments, or monitoring tests, which may add further expense.

It is worth noting that private health insurance policies in the UK rarely cover outpatient prescription medications for chronic conditions. Some policies may contribute towards specialist consultations, but patients should check their specific policy terms and not assume medication costs will be covered.

Given the substantial cost difference between NHS and private routes, patients should explore all available options and discuss eligibility with their healthcare provider. Financial considerations should be balanced against clinical need and long-term health outcomes.

Private Prescription Costs for Mounjaro

Accessing Mounjaro via a private prescription involves several cost components beyond the medication itself. Patients typically need to pay for an initial consultation with a private GP or specialist, which can range from £183.94–£313.94 depending on the clinic and whether the appointment is conducted in person or online. During this consultation, the clinician will assess your medical history, current medications, and suitability for Mounjaro, often requiring blood tests to evaluate kidney function, liver enzymes, and HbA1c levels.

Once a prescription is issued, the cost of the medication itself varies by dosage strength. Mounjaro is available in several doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg). The licensed titration schedule typically starts at 2.5 mg weekly, with increases in 2.5 mg steps at minimum 4-week intervals based on response and tolerability. A pack of 4 single-use pens (one month's supply) may cost around £183.94–£313.94 at lower doses, while higher doses may cost £183.94–£313.94 per pack, though prices vary between providers.

Additional costs include follow-up consultations to monitor treatment response, adjust dosing, and screen for adverse effects. During dose titration, reviews may be needed every 4-8 weeks, then every 3-6 months once on a stable dose. These appointments typically cost £183.94–£313.94 each. Some private clinics offer package deals that bundle consultations, prescriptions, and monitoring into a monthly or quarterly fee.

Patients should also budget for blood tests and monitoring, which may not always be included in consultation fees. Provision of a sharps bin for safe disposal of used pens is another consideration. It is advisable to request a full cost breakdown before committing to private treatment, and to compare prices across different providers. Always ensure you use GMC-registered prescribers, CQC-registered clinics, and GPhC-registered pharmacies.

Factors That Affect Mounjaro Pricing

Several factors influence the overall cost of Mounjaro treatment in the UK. Dosage strength can affect pricing, with different strengths potentially having different costs depending on the provider. Patients often start on a lower dose (2.5 mg) and titrate upwards according to the licensed schedule, which may impact monthly costs over time.

Pharmacy choice also plays a significant role. High-street pharmacies, online pharmacies, and specialist clinics may charge different dispensing fees and mark-ups. Online providers sometimes offer competitive prices, but patients should ensure they are using a registered and regulated pharmacy (check the General Pharmaceutical Council register).

Geographical location can affect consultation fees, with London and other major cities typically charging more for private appointments than rural or regional clinics. Telemedicine services have become increasingly popular, offering remote consultations at competitive rates, though patients should verify the credentials and regulatory status of any online provider.

The inclusion of ancillary services such as blood tests, dietetic support, and follow-up monitoring can significantly impact total costs. Some clinics bundle these services, while others charge separately. Patients should clarify what is included in quoted prices.

Finally, supply and availability factors can influence pricing. Mounjaro is subject to the same supply constraints affecting many GLP-1 receptor agonists in the UK, which may impact both availability and pricing. NHS England and the Department of Health and Social Care periodically issue supply disruption alerts with guidance for healthcare professionals.

Patients are encouraged to discuss cost concerns openly with their healthcare provider, who may be able to suggest more affordable alternatives or access schemes. Prices and availability may change over time, so it's advisable to check current costs before making treatment decisions.

Ways to Access Mounjaro Treatment in the UK

There are several pathways to access Mounjaro in the UK, each with distinct eligibility criteria and cost implications. NHS prescription is the most cost-effective route for eligible patients. For type 2 diabetes, access is typically governed by NICE guidance (NG28) and local formulary decisions. For weight management, NICE has published specific criteria regarding BMI thresholds and comorbidities. Patients should discuss their eligibility with their GP, who can initiate treatment or refer to a specialist service if appropriate.

For those who do not meet NHS criteria or prefer faster access, private prescription is an alternative. This can be obtained through private GPs, endocrinologists, weight management specialists, or online telemedicine platforms. Patients should ensure that any private provider conducts a thorough medical assessment and provides ongoing monitoring.

Important safety considerations include watching for signs of pancreatitis (severe, persistent abdominal pain, sometimes with vomiting) or gallbladder problems, which require urgent medical attention. If you use oral contraceptives, you should use additional contraceptive methods or switch to non-oral contraception for 4 weeks after starting Mounjaro and after each dose increase. If you also take insulin or sulfonylureas, dose reductions may be needed to prevent hypoglycaemia.

Patient access schemes and clinical trials may occasionally offer Mounjaro at reduced cost or free of charge. Patients can search for UK clinical trials through the NIHR Be Part of Research website.

Some private health insurance policies may cover specialist consultations, though coverage for outpatient medications is uncommon in UK policies. Patients should contact their insurer to confirm what is covered.

Finally, patients should be aware of the risks of obtaining Mounjaro from unregulated sources. Always use a registered UK pharmacy and ensure your prescription is issued by a qualified, UK-registered prescriber. If you experience any side effects, report them through the MHRA Yellow Card scheme and contact your healthcare provider or NHS 111 promptly.

Frequently Asked Questions